throbber

`
`Complement I: 147—159 (1984)
`
`01984 S. Karger AG, Basel
`0253—5075/34/0013-0147sz.7s/o
`
`Quantification of C1 -Inhibitor Functional Activities by
`Immunodiffusion Assay in Plasma of Patients with Hereditary
`Angioedema @ Evidence of a Functionally Critical Level of
`Cl-Inhibitor Concentration
`
`P.J. Spc'ith 3. B. Wi‘ithrich 1’, R. Bt‘t’tlera
`
`4‘ Blood Transfusion Service SRC, Central Laboratory, Berne;
`bDermatological Clinic, Allergy Unit, University Hospital, Zurich, Switzerland
`
`Key Words. Attenuated androgens - Hereditary angioedema - Cl-inhibitor « C4 -
`Immunodiifusion assay
`
`Abstract. The relationShip of Cl-inhibitor (Cl-INH) concentration and apparent func-
`tional activity was investigated in 11] plasma samples from 21 patients with the common
`form of hereditary angioedema (HAE). Functional Cl-lNH was analyzed by means of a modi-
`fied version ofimmunodilfusion assay. Down to a Cl-lNl—I level of approximately 0.075 g/l
`(38% of normal) apparent Cl-lNl—l functions were found within the normal range, while
`below this level functional adequacy of Cl-lNH could no longer be ascertained. When C4
`concentrations, considered to reflect approximately functional Cl-lNH, were related to Cl-
`INH antigen levels of individual samples, a relationship emerged which was identical to that
`between Cl-INH concentration and apparent function. No attacks of edema could be associ-
`ated with Cl-lNH concentrations above 0.075 2/], while it was possible to associate attacks
`with concentrations below this level. In experiments where patient plasma and normal plasma
`were mixed in various ratios or where HAE plasma was replaced by purified Cl-lNH, an
`increase in Cl-lNH antigen to concentrations of 0.06-0.08 g/l was followed by a sharp rise in
`apparent functions to normal values. The rise of functional C l-lNl-l became moderate when
`Cl-IN H antigen further increased. The results supported the idea of a functionally critical
`level ofCl-INl'l in the common form ofHAE.
`
`Introduction
`
`All these inhibitors become modified by the
`serine proteases which they inactivate [I].
`
`The serine proteases inhibited by Cl-lNH
`is a regulatory
`Cl-inhibitor (Cl-INH)
`are the active forms of the two enzymatic
`plasma protein. This uz-glycoprotcin belongs
`subunits of the first component of comple-
`to a class of inhibitors such as al-pi'oteinase
`inhibitor, antithrombin III and antiplasmin. ment, Clr and C15, and also plasmin, kalli-
`
`This materislwss copied
`stzhe NLM and may be
`Subjnt USCcpyright law:
`
`Page 1 of 13
`
`CSL EXHIBIT 1083
`
`Page 1 of 13
`
`CSL EXHIBIT 1083
`
`

`

`148
`
`
`
`Spéith/Wiithrich/Biitler
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`krein and coagulation factors Xla, XIIa and
`
`
`
`
`
`
`XIIf[2—8]. In addition, Cl-INH controls the
`
`
`
`
`autoactivation of zymogen Clr [9].
`
`
`
`
`
`
`
`A variety of clinical symptoms may be
`
`
`
`
`
`
`associated with reduced functional activity of
`
`
`
`
`
`Cl-INH. In hereditary angioedema (HAE)
`
`
`
`
`
`the reduced Cl-INH functional activity in-
`duces recurrent attacks of edema of the ex-
`
`
`
`
`
`
`
`
`
`
`
`
`
`tremities, the gastrointestinal tract, the face
`
`
`
`
`
`
`
`
`or the larynx, and death may result from air-
`
`
`
`
`
`way obstruction [10]. Affected persons are
`
`
`
`
`
`
`
`heterozygous for a defect of the Cl -INH pro-
`
`
`
`
`
`
`
`
`
`
`tein gene [1 1]. In the common form of the
`
`
`
`
`
`
`
`disease, the reduction in functional activity is
`
`
`
`
`
`
`due to Cl-INH concentrations being only 5—
`
`
`
`
`
`
`
`
`
`30% of normal. In the variant form of the
`
`
`
`disease, immunochemically detectable con-
`
`
`
`
`
`
`centrations of Cl-INH are normal or ele-
`
`
`
`
`
`
`vated, but a dysfunctional mutant protein is
`
`
`
`
`
`
`synthesized [12]. A reduction of functional
`
`
`
`
`
`
`Cl-INH may also be acquired; such condi-
`
`
`
`
`
`
`
`
`tions may or may not be associated with
`
`
`
`
`
`
`reduced antigen levels [13, 14]. Furthermore,
`
`
`
`
`
`
`functional
`inadequacy of Cl-INH can be
`
`
`
`
`
`
`
`
`transient without any decrease in the level of
`
`
`
`
`
`Cl-INH [15]. Thus the unequivocal diagno-
`
`
`
`
`
`
`
`
`sis of all Cl-INH deficiency stages is based
`
`
`
`
`
`on the demonstration of a functionally inade-
`
`
`quate Cl-INH.
`
`
`
`
`
`
`Recently, Ziccara’i and Cooper [16] de-
`
`
`
`
`
`
`scribed a simple and easily performable assay
`
`
`
`
`
`system for assessment of Cl-INH functional
`
`
`
`
`
`activity. Unlike other methods, no special-
`
`
`
`
`
`
`
`ized techniques are needed and all reagents
`
`
`
`
`are commercially available. Furthermore,
`
`
`
`
`
`
`
`
`
`
`this assay system is the only one where one of
`
`
`
`
`
`
`
`
`the natural substrates of Cl-INH, Clr, in its
`
`
`
`
`
`physiologic concentration serves directly as
`
`
`
`
`
`
`
`an indicator of functional activity of the in-
`
`
`
`
`
`
`
`
`hibitor. So far a drawback of this assay sys-
`
`
`
`
`
`
`
`
`tem was the lack of a valid method to quan-
`
`
`
`tify functional Cl-INH.
`
`
`
`
`
`
`
`
`
`
`A modification of the immunodiffusion
`
`
`
`
`
`
`
`
`
`
`
`
`
`assay is proposed in this study which allows
`
`
`
`
`
`
`quantification of functional Cl-INH. It was
`
`
`
`
`
`
`
`used to investigate routinely the plasma of a
`
`
`
`
`
`
`large number of patients for functional C1-
`
`
`
`
`
`
`INH and to select those patients suffering
`from the common form of HAE. A further
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`aim of this study was to reinvestigate the
`
`
`
`
`
`
`effect of attenuated androgens in the com—
`
`
`
`
`
`
`mon form of HAE. Indeed,
`the literature
`
`
`
`
`
`reports that therapy with impeded androgens
`
`
`
`
`
`prevents attacks of angioedema and normal-
`
`
`
`
`
`
`izes the concentration of the fourth compo—
`
`
`
`
`
`
`nent of complement. However, there are con—
`troversies about the effect on the level of Cl-
`
`
`
`
`
`
`
`
`
`
`
`
`
`INH antigen [17—23]. The results presented
`
`
`
`
`
`
`
`
`in this study suggest that there is a function—
`
`
`
`
`
`
`
`ally critical level of Cl-INH concentration of
`
`
`
`
`
`
`
`approximately 0.075 g/l (38% of normal),
`
`
`
`
`
`
`above which apparently normal function of
`Cl-INH and thus normal concentrations of
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`C4 seem to be assured in the plasma ofpatients
`
`
`
`
`
`
`
`affected by the common form of HAE.
`
`
`
`Patients and Methods
`
`
`
`
`
`
`
`
`
`
`Subjects
`
`21 patients were studied, 15 women and 6 men, all
`
`
`
`
`
`
`
`
`
`suffering from the common form of HAE. In each
`
`
`
`
`
`
`
`
`case, diagnosis was made on the basis of clinical and
`
`
`
`
`
`
`
`
`
`family history as well as on serological findings. Of the
`
`
`
`
`
`
`
`
`
`111 plasma samples analyzed, 22 were from 13 pa-
`
`
`
`
`
`
`
`
`tients receiving no therapy. 2 of these 13 patients were
`
`
`
`
`
`
`
`
`
`
`eventually treated with attenuated androgens and 1
`
`
`
`
`
`
`
`with tranexamic acid. 5 samples were collected from 3
`
`
`
`
`
`
`
`
`
`patients receiving therapy with tranexamic acid.
`I of
`
`
`
`
`
`
`
`
`these patients was later treated with danazol. 7 pa-
`
`
`
`
`
`
`
`
`tients were managed by danazol or stanozolol (Win-
`
`
`
`
`
`
`
`throp, Basel, Switzerland). 84 samples originated from
`
`
`
`
`
`
`
`this group of patients.
`
`
`
`
`
`Laboratory Methods
`
`
`Heat-aggregated human lgG (aIgG) was prepared
`
`
`
`
`
`
`by heating a solution of 16 mg/ml for 20 min to 63 °C.
`
`
`
`
`
`
`
`
`
`
`
`
`After cooling and centrifugation for 15 min at 1,500 g
`
`
`
`
`
`
`
`
`
`
`
`This mate rial was copied
`
`
`
`
`
`
`aims NLM and may be
`
`
`
`
`SL5 Eject U5 Earp-yright Laws
`
`
`
`
`
`
`Page 2 of 13
`
`Page 2 of 13
`
`

`

`Functionally Critical Level of C l-INH Concentration
`
`
`
`
`
`
`
`149
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`INH. The method proposed estimates func-
`
`
`
`
`
`
`
`
`tional Cl-INH by calculating the slope of the
`
`
`
`
`
`
`
`regression line formed when the added aIgG
`
`
`
`
`
`
`concentrations are plotted against ratios of
`
`
`
`
`
`
`immunologically detectable Clr in the 5 ali-
`
`
`
`
`
`
`
`
`quots of the recalcified plasma sample to be
`
`
`
`
`
`
`analyzed. To obtain a significant coefficient
`
`
`
`
`
`
`
`of regression (r2), it proved useful first to cal-
`
`
`
`
`culate the percentages of immunologically
`
`
`
`
`
`
`
`
`detectable Clr in the 5 aliquots. The Clr con-
`
`
`
`
`
`
`
`tent of plasma pooled from 50 healthy blood
`
`
`
`
`
`
`donors served as reference (=100%). Accu-
`
`
`
`
`
`
`
`
`racy of Clr quantification from day to day
`
`
`
`
`
`
`
`
`
`
`
`was i 5 % (n = 45). To avoid a dependency of
`
`
`
`
`
`
`apparent functional activity of Cl-INH on
`
`
`
`
`
`
`
`
`levels of Clr, calculation of the ratios of
`
`
`
`
`
`immunologically detectable Clr in the ali-
`
`
`
`
`
`
`quots A0_4 was a prerequisite. Calculation in
`
`
`
`
`
`
`parallel of the regression lines in individual
`
`
`
`
`
`serum and recalcified citrate plasma samples
`
`
`
`
`
`
`from 50 healthy blood donors generally re-
`
`
`
`
`
`
`
`
`
`sulted in a higher r2 value for the recalcified
`
`
`
`
`
`plasma samples. Quantification of functional
`
`
`
`
`
`
`
`
`Cl-INH in EDTA plasma proved not to be
`
`
`
`
`
`possible, even though Ca2+ and Mg“ were
`
`
`added in a 10-fold excess.
`
`
`
`
`
`
`
`
`
`
`
`
`
`In each run of analyses the slope of the
`
`
`
`
`
`regression line of recalcified plasma pooled
`
`
`
`
`
`
`
`from 50 healthy blood donors was also esti-
`
`
`
`
`
`
`
`
`
`
`
`mated and was set at 100% (in fig. 1, b =
`
`
`
`
`
`—0.577). The percentage of Cl-INH func-
`
`
`
`
`
`
`
`tional activity in plasma from a HAE pa-
`
`
`
`
`
`
`
`
`
`
`tient is reflected by the value of the slope of
`
`
`
`
`
`
`
`
`
`
`the regression line (in fig. 1, b = -—0.196) and
`
`
`
`
`
`
`
`
`can be calculated as given in this example
`
`
`
`
`
`
`
`(fig. 1):
`(—0.196/—0.577) X 100% = 34%.
`
`
`
`
`
`
`
`The accuracy of the determination within 1
`
`
`
`
`
`
`
`
`
`
`
`day was found to be i 10% (n = 15) and
`
`
`
`
`
`
`
`
`
`
`
`
`
`from day to day to be i 13% (n = 45). The
`
`
`
`
`
`
`normal range of functional Cl-INH levels
`
`
`
`
`
`
`varied between 70 and 135% (95% confi-
`
`
`dence interval).
`
`
`
`the protein concentration was adjusted to exactly
`
`
`
`
`
`
`15 mg/ml.
`
`
`Concentrations of C4 and Cl-INH were deter-
`
`
`
`
`
`
`mined nephelometrically (Hyland) and by single radial
`
`
`
`
`
`
`
`immunodiffusion (RID), respectively. Standards from
`
`
`
`
`
`Atlantic Antibodies (Merz + Dade, Diidingen, Swit-
`
`
`
`
`
`
`zerland) and from Hyland (Travenol, Switzerland)
`
`
`
`
`
`served as references. Purified, functionally active C1-
`
`
`
`
`
`
`INH was kindly donated by II.P. Kocher, University
`
`
`
`
`
`
`
`of Geneva, Switzerland.
`
`
`
`
`
`
`
`
`
`
`Quantification of Functional CI—INH by the
`
`
`
`
`
`Immunodiffusion Method
`
`
`9 volumes of blood were drawn into siliconized
`
`
`
`
`
`
`
`
`glass tubes containing 1 volume of0.11 mol/l trisodium
`
`
`
`
`
`
`
`citrate. After adequate mixing and centrifugation,
`
`
`
`
`
`
`plasma was stored in plastic tubes at —70 °C. To 495 pl
`
`
`
`
`
`
`
`
`
`
`
`plasma 5 pl of 2 mol/l CaClz solution was added. The
`
`
`
`
`
`
`
`
`
`
`formed clot was removed and the supernatant was
`
`
`
`
`
`
`
`
`divided into 5 aliquots of 80 ul (A04); aIgG solution
`
`
`
`
`
`
`
`
`
`
`was added to 4 of the aliquots to obtain final concen-
`
`
`
`
`
`
`
`
`
`
`tration of 0.25 (A1), 0.5 (A2), 1.0 (A3) and 1.5 mg
`
`
`
`
`
`
`
`
`
`
`
`aIgG/ml (A4). The volumes of the aliquots were ad-
`
`
`
`
`
`
`
`
`justed to 100 pl with isotonic saline. To the 5th of the
`
`
`
`
`
`
`
`
`
`
`
`aliquots (A0) 20 ul isotonic saline was added. The mix-
`
`
`
`
`
`
`
`
`
`tures were incubated for 60 min at 37 °C. Incubation
`
`
`
`
`
`
`
`
`
`
`was stopped by the addition of6 ul of0.2 mol/l EDTA,
`
`
`
`
`
`
`
`
`
`
`pH 7.4. In each run, pooled plasma from 50 healthy
`
`
`
`
`
`
`
`
`
`
`blood donors was treated the same way. Clr levels in
`
`
`
`
`
`
`
`
`
`
`A04 were assessed by RID in 1 % (w/v) agarose, pH 8.0,
`
`
`
`
`
`
`
`
`
`
`
`containing 3.25% (v/v) ofan IgG fraction ofgoat anti-
`
`
`
`
`
`
`
`
`
`
`human Clr (Atlantic Antibodies). The Clr contents of
`
`
`
`
`
`
`
`
`various dilutions of the aliquot of the pooled plasma
`
`
`
`
`
`
`
`
`
`that did not receive aIgG served as a calibration curve.
`
`
`
`
`
`
`
`
`
`Ratios ofClr were formed by dividing the percentage of
`
`
`
`
`
`
`
`
`immunologically detectable Clr in A04 by the C 1 r level
`
`
`
`
`
`
`
`
`
`in A0. In order to quantifiy Cl—INH functional activity,
`
`
`
`
`
`
`
`
`
`the logarithms of the added aIgG concentrations were
`
`
`
`
`
`
`
`
`plotted against ratios ofClr in the aliquots and the slope
`
`
`
`
`
`
`
`
`
`
`
`of the regression line was calculated.
`
`
`
`
`
`
`
`
`
`Results
`
`
`
`
`
`
`
`Quantification of Functional CI-INH by
`
`
`Immunodiffitsion Assay
`
`
`
`
`
`The immunodiffusion assay of Ziccardi
`
`
`
`
`
`
`
`
`
`and Cooper [16] was modified in such a way
`
`
`
`
`
`
`
`as to allow quantification of functional C1-
`
`
`
`Th is mate rial was copied
`
`
`
`
`
`
`aims NLM and may DE
`
`
`
`
`EL: Eject U5 Copyright Laws
`
`
`
`
`
`
`Page 3 of 13
`
`
`
`
`
`
`Page 3 of 13
`
`

`

`ISO
`Spath/Wiithrich/Bfitler
`
`Functional Adequacy of C1 -INII in the
`Common Form of HAE
`Figure 2 gives an overview of the relation-
`ship between C 1 -INH concentrations and ap-
`parent functions in clinical conditions. These
`include the common and the variant form of
`
`HAE (sample of the variant form kindly pro-
`vided by C. Alper. Boston. USA), acquired
`Cl-INH deficiency with complete remission
`and normalization of various complement
`parameters for 6 months after surgical re-
`moval ofa giant myoma of the fundus uteri,
`deficiencies and dysfunctions of components
`ofcomplement other than Cl-lNH, hypo- or
`agammaglobulinemia, immune complex dis-
`eases, acute and chronic idiopathic thrombo-
`cytopenic purpura, malignancies, bacterial
`and viral infections and urticaria. The results
`
`indicate a correct quantification of functional
`Cl-lNH in cases of the acquired and variant
`forms of angioedema. However, in l
`l l recal-
`cifted plasma samples from 21 patients with
`the common form of HAE, unexpectedly
`high functional activities associated with
`subnormal levels of (‘l-INH were observed.
`
`A closer view of (‘l-lNH antigen levels and
`related functions in these samples is given in
`figure 3a. The association of apparently nor—
`mal function and abnormally low Cl-INH
`level was found almost exclusively in recal—
`cificd plasma from patients treated with at-
`tenuated androgens. Among the 23 samples
`with Cl-lNH levels above 0.075 g/l (38% of
`normal) only 1 sample (4%) displayed an
`apparently inadequate Cl-INH function. In
`contrast, among the 88 samples with Cl-INH
`concentrations below 0.075 g/l 65 (74%)
`showed functionally inadequate Cl-lNH.
`In the range of 0035—0075 g/l Cl-lNH
`antigen the functional activities could vary
`from 10 to 135% ofnormal, and in 1 sample
`an apparent Cl-lNH function as high as
`
` V7r“fr )Iv..'J
`
`airy, vl'l’lWJv mghul
`
`2‘:w'_>
`._')
`'3
`3-}(I
`
`Fig. l. Quantification ofCl-INH functional activ-
`ity in HAE using the immunodilTusion method. The
`regression lines between the concentrations of added
`algG and the ratios of immunologically detectable C l r
`in aliquots (A04) of recalcified plasma pooled from
`healthy blood donors (0) and in aliquots of recalcified
`plasma from a patient (0) are shown. The coefficients
`of correlation (r3) in the examples given were 0.999 (D)
`and 0.99] (0), respectively.
`
`156% emerged (open circle in fig. 3a). This
`and all other samples with extremely diver~
`gent Cl-INH concentrations and apparent
`functions were collected from patients with
`manifest infections or from patients where a
`subclinical infection was strongly suspected.
`
`Thus, the most extemc Cl-lNH concentra—
`tion and related function (0.02 g/l and 85 %,
`respectively; one of the open triangles in
`fig. 3a) were seen in the plasma from a pa-
`tient with an abscess on his neck. All other
`markedly divergent concentrations and func-
`tions were observed only in recaleified
`plasma from members ofa particular family.
`All these patients were heterozygous for the
`Cl-INH and the factor I
`(C3b/C4b-INA)
`protein gene, and some of them even showed
`
`this material wascopied
`It the NLM and MW be
`Subject US Copyright Laws
`
`Page 4 of 13
`
`Page 4 of 13
`
`

`

`l5l
`Functionally Critical Level ol‘(‘l-lNH Concentration
`
`150
`
`10!} .
`
`so -
`
`
`
`Fig. 2. (.‘l-lNH concentrations and
`apparent functions in 364 rccalcificd
`plasma samples analyzed routinely. The
`symbols indicate samples from patients
`with the common form of HAE under
`various therapeutic regimens (0), ac-
`quired angioedema before and after sur-
`gical intervention (D). the variant form
`of HAE (A). the common form ol'HAE
`after infusion of (‘l-lNH concentrate
`(I), HAE under discussion (0) and
`plasma samples from members of HAE
`families (A), or from subjects with var-
`ious other diseases (see text) ( + ). Nor-
`mal 95% range ofimmunologically de-
`tectable Cl -lNH is given by the vertical
`and of functional (‘l-lNH by the hori-
`zontal. partially dotted. lines.
`
`a
`
`w—w-I
`Fewxici'tdl
`
`‘11
`O
`Cielrlll Ll!lll'.]"ll‘ tjll
`
`0.7
`
`0.3
`
`(1/.
`
`depressed plasma concentrations of C4-bind-
`
`ing protein. Levels of C3 were usually found
`below the lower limit ofthe normal range and
`the patients had prolonged phases of infec-
`tions.
`
`Figure 3a does not clearly indicate the re-
`lationship of (‘l-INH concentration and
`
`function in the samples analyzed. However,
`when Cl-lNH antigen was ranged in classes
`of 0.02 g/l, as indicated by bars in figure 3b.
`the means of CI-INH concentrations and
`
`apparent functions of the individual classes
`
`clearly indicated a nonlinear relationship.
`Two approaches calculating the relationship
`between concentration and function were
`
`made. In a first attempt, the regression lines
`of concentrations and functions in samples
`with Cl-INH levels in the ranges 0.012—0.08
`and 0.08—0.13 g/l, respectively. were calcu-
`lated. For this purpose, individual Cl-lNH
`concentrations and functions of plasma sam-
`
`plcs as given in figure 3a were considered.
`The two regression lines are shown in figure
`3b. In a second attempt the regression line
`was calculated after logit transformation of
`apparent (‘l -lNH function. Such transforma-
`tion requires values below 100%. Thus,
`it
`was reasonable to do a calculation using the
`mean values of functional Cl-INH as given
`
`in figure 3b. The use of the mean values
`ensured that the corresponding functional ac-
`tivities of an equivalent of Cl-lNH antigen
`up to a concentration of 0.09 g/l were taken
`into consideration. The retransformed values
`
`of the calculated regression line are given in
`figure 3b. Both calculations indicated that a
`concentration of Cl-lNH antigen of 0.07—
`
`0.08 g/l represents a threshold level for Cl-
`lNH function.
`
`The concept of a functionally critical level
`of Cl-INH concentration was further sup-
`
`ported by relating CI-lNH concentration to
`
`This material was copied
`at the ML“ and may be
`Subjut US Copyright Law:
`
`Page 5 of 13
`
`

`

`I52
`Spa'lh/Wiithrich/Bfillcr
`
`
`
`
`150
`
`0
`
`a: 10
`I
`Z
`,I_
`U 50
`a
`5
`U

`1.5
`
`o
`
`c
`

`A
`o .
`o
`.C . .
`O.
`.
`.
`a .
`a0...-
`.“
`o ..
`o
`.0
`.‘ O
`o 55.
`‘0’ °
`v
`t
`D
`0 all.
`“g -- °
`
`f—‘I—I
`A
`
`0
`._L
`
`04
`

`
`a
`
`M
`
`d
`
`1
`
`l
`
`’1
`
`T‘b
`
`._
`
`FT
`
`,
`
`I
`
`ll
`
`_
`
`a
`“" I
`M
`e
`
`‘
`
`c
`
`.
`
`_
`

`
`0
`
`e
`
`'
`
`I
`
`’I
`
`/I
`
`0.3
`
`02
`
`01
`
`0
`
`a
`OI
`C~
`"’
`t‘
`.5."
`E1
`a
`
`0
`
`AA A. o
`A
`0A A!
`A
`'1. "
`$.A...’ ‘
`.
`o
`‘ 91‘ °
`W
`a...
`«J
`v
`g D
`
`.V DE:
`’0
`le ' ‘1—fi' TT r
`" mgrflT'Ti—T
`0.05
`0.1
`0.15
`U 05
`O 'l
`Ci-lNH antigen, gll
`
`A
`
`‘
`
`.
`
`,’
`
`’
`
`___
`
`._
`
`,
`
`o
`
`0.15
`
`Fig. 3. Quantification of Cl-lNH and C4 antigen
`and functional (‘l-lNH in lll individual plasma sam-
`ples from 2| patients with the common form ofHAE.
`The vertical lines indicate the lower limit of the nor-
`mal range (—2 SD) of Cl-lNH concentration. The
`horizontal lines represent the lower and the upper lim-
`its ofthe normal range (1 2 SD) ofapparcnt ('l-lNH
`function, respectively.
`:1 Plot of individual Cl—INH
`antigen levels against apparent functional activities.
`The therapeutic management of the patients at the
`time when the samples were collected is indicated: no
`therapy (C1), therapy with tranexamic acid (v). therapy
`with danazol (e) or slanozolol (A). A or o = Samples
`from patients with present or recent bacterial or viral
`infections and therapy with danazol or stanozolol; a =
`Cl-lNH concentrations and functions in samples
`from an asymptomatic woman, a member of the
`family with concomitant heterozygoty for the C l -INH
`and the factor I protein gene, herself heterozygous only
`for Cl-lNH. b Means ( :1 SD) ofCl-lNH concentra-
`tions and functions as can be calculated when ranges
`
`of Cl-lNH antigen levels are formed. Limits of the
`ranges were 6—15, 16-25.
`56—67 % of normal con-
`centration (100% = 0.]96 g/l). 0 = Calculated curve
`of mean (‘l-lNH concentrations versus logit trans-
`formed and retmnsformed mean functional activi-
`ties; ——— = regression lines between individual (‘1-
`lNH concentrations in the ranges 6-40 and 41-67%
`of normal and associated functions.
`respectively.
`c C l-INH antigen levels and manifestation of attacks
`of edema. o = Cl-lNH concentrations in plasma col-
`lected after an attack; 0 = mean concentrations or
`two different quantifications. During the period of
`quantification an attack was observed. but the time
`between the plasma collections was too long to per-
`mit direct correlation of (‘l-lNH concentration and
`attack of edema. d Individual Cl-lNH levels, plotted
`against C4 concentrations. The symbols used are the
`same as in a. e Means (i 1 SD) ofCl-lNH and (‘4
`concentrations as can be calculated when ranges of
`C l-INH antigen levels are formed. Symbols and ex-
`planations as in b.
`
`This material was copied
`at the ML" and may be
`Subject US Cowman: Laws
`
`Page 6 of 13
`
`

`

`153
`Functionally Critical Level of Cl-lNH Concentration
`
`
`
`
`
`
`
`
`
`
`
`
`manifestations of angioedema. Cl—INH con-
`
`
`
`
`
`
`
`
`centrations above 0075 g/l (38% of normal)
`
`
`
`
`
`
`
`
`
`could not be related to an attack of edema,
`
`
`
`
`
`
`
`
`while in all samples collected after an attack
`
`
`
`
`
`
`
`Cl-INH concentrations were below 0.075 g/l
`
`
`
`
`
`
`
`(fig. 3c). Attacks were most frequent when
`
`
`
`
`
`
`
`
`Cl-INH levels were below 0.035 g/l (18% of
`
`normal).
`
`
`
`
`
`
`
`
`Relationship between (“I-[NH and ('4
`
`
`
`
`
`Concentrations in the Common Form of
`HAE
`
`
`
`
`
`
`In HAE a close relationship between func-
`
`
`
`
`
`
`
`
`tional Cl-INH and levels of C4 antigen is
`
`
`
`
`
`
`
`assumed. The assumption of such a close
`
`
`
`
`
`
`relationship is widely accepted and serves
`
`
`
`
`worldwide for routine laboratory approxima—
`tion of functional Cl-INH in HAE. Thus.
`
`
`
`
`
`
`
`
`
`
`
`quantification ofC4 levels by routine labora—
`
`
`
`
`
`
`tory technique in parallel to Cl-lNH func—
`
`
`
`
`
`
`
`tion offered a chance to verify the correctness
`
`
`
`
`
`
`
`ofthe method proposed for quantification of
`
`
`
`
`
`
`
`Cl-INH function. Figure 3d depicts the rela-
`tionship between Cl-INH and C4 concentra-
`
`
`
`
`
`
`
`
`
`
`
`tion ofindividual samples. Analogous to the
`
`
`
`
`
`
`
`results as given in figure 3a , Cl-INH concen—
`
`
`
`
`
`
`
`trations above 0.075 g/l were associated with
`
`
`
`
`
`
`C4 levels within the normal range. Further-
`
`
`
`
`
`
`
`more, Cl-INH antigen within a range of
`
`
`
`
`
`
`
`0035—0075 g/l could be associated with C4
`
`
`
`
`
`concentrations of 0.03—0.25 g/l. Finally, be—
`
`
`
`
`
`
`
`low a Cl-INH concentration of 0.035 g/l C4
`
`
`
`
`
`
`
`levels were greatly reduced. When the same
`
`
`
`
`
`
`
`procedure was applied to results presented in
`
`
`
`
`
`
`
`
`figure 3d as was applied to parameters in fig-
`
`
`
`
`
`
`
`
`
`
`ure 3a to obtain the results in figure 3b, a
`
`
`
`
`
`nonlinear relationship between Cl-INH and
`
`
`
`
`
`
`C4 concentrations became apparent (fig. 3e).
`
`
`
`
`
`Again a Cl-INH threshold level of0.07—0.08
`
`
`
`
`
`
`
`g/l was found, above which normal C4 con-
`
`
`
`
`
`
`centrations seemed to be assured in patients
`
`
`
`
`
`
`
`suffering from the common form of HAE.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`CI-INII Functions in illixtures ofllAE
`and Normal Plasma and in IIAE Plasma
`
`
`
`
`
`
`
`
`
`
`Replaced by Purified C1 -INH
`
`
`
`
`
`
`
`The results in figure 3a reflect the fluctua-
`tion in Cl-INH concentration and apparent
`
`
`
`
`
`
`
`
`
`
`
`
`function in the plasma of various HAE indi-
`
`
`
`
`viduals receiving various therapeutic regi-
`
`
`
`
`
`
`
`mens. The results imply, but do not conclu-
`
`
`
`
`
`sively prove, a nonlinear relationship be-
`tween Cl-INH concentration and apparent
`
`
`
`
`function. To obtain more evidence of the
`
`
`
`
`
`
`
`
`
`
`
`
`existence ofa functionally critical level ofCl-
`
`
`
`
`
`INH concentration, recalcified plasma from
`2 individuals with the common form of HAE
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`was used for further in vitro studies. At the
`
`
`
`
`
`
`
`time of plasma collection both patients were
`
`
`
`
`
`
`
`receiving tranexamic acid and thus had low
`Cl-INH concentrations and functions. The
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`concentration of factor B in the plasma from
`
`
`
`
`
`
`
`1 of these patients was elevated, indicating
`
`
`
`
`
`
`
`
`that
`there was, or recently had been. an
`
`
`
`
`inflammatory
`process.
`The
`recalcifled
`
`
`
`
`
`
`
`
`
`plasma ofthe patient with a normal factor B
`concentration was mixed in various ratios
`
`
`
`
`
`
`
`
`
`
`
`
`with recaleified plasma from a healthy per—
`
`
`
`
`son. Cl-INH concentration and apparent
`
`
`
`
`
`
`function of the mixtures were quantified and
`
`
`
`
`
`
`
`
`the results are shown in figure 4. To demon-
`
`
`
`
`
`strate the relationship between Cl-INH con-
`
`
`
`
`
`centration and apparent function, the regres-
`
`
`
`
`
`
`
`sion lines ofthese parameters within Cl-INH
`
`
`
`
`
`concentration ranges of 0.02—0.06 and 0.06—
`
`
`
`
`
`
`0.18 g/l, respectively, were calculated. Again
`
`
`
`
`
`
`a disproportionately rapid rise of apparent
`
`
`
`
`function over
`immunologically detectable
`
`
`
`
`
`Cl-INH emerged in the Cl-INH concentra-
`
`
`
`
`
`
`tion range of 0.02—0.06 g/l. This dispropor-
`tion was reversed as soon as Cl-lNH concen-
`
`
`
`
`
`
`
`
`tration exceeded a value of 0.06 g/l.
`
`
`
`
`
`
`
`
`
`
`
`
`The study described above was repeated
`
`
`
`
`with plasma containing elevated concentra-
`tions of factor B. A rise in Cl-INH concen-
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Thia material was applied
`
`
`
`at the NLM and may be
`
`
`
`
`
`
`Subject US Copyright Laws
`
`
`
`
`
`Page 7 of 13
`
`Page 7 of 13
`
`

`

`154
`Spa‘th/Wiithrich/Biillcr
`
`tration from 0.035 to 0.065 g/l was associ-
`ated with an overshoot
`in apparent func-
`tional activity reaching values of 180%. A
`further rise in Cl-lNH antigen as a result of
`the addition of normal recalcificd plasma re-
`sulted in a constant decrease of apparent
`functional activity to the values of the recal-
`cified normal plasma (fig. 5). Replacement of
`the HAE plasma containing elevated concen-
`trations of factor B by increasing amounts of
`purified Cl -1NH led again to an initially dis-
`proportionate rise in apparent functions; at a
`concentration of0.075 g/l the apparent func-
`tion of Cl-INH was approximately 100%
`and subnormal concentrations of Cl-lNH
`
`around 0.1 g/l were associated with apparent
`
`functions above the upper limit of normal. A
`rise in Cl-lNH concentration from 0.1 to
`
`0.35 g/l showed little effect on functional Cl-
`lNH (fig. 5).
`
`1‘/1
`
`VJ)
`
`
`
`
`
`'1-l\.‘l-_‘1.t.
`
`“‘é.
`v-;-lc,
`
`r——fi'
`C 1
`”()5
`(J
`",1 11111 'lll'lq‘fll' g/l
`
`r
`
`l 7 t
`010
`
`
` ,FA.
`
`I
`
`-e
`
`I
`111‘;
`
`Fig. 4. Concentrations and functions ofCl-lNH in
`rccalcified mixtures with varying ratios of HAE
`plasma and normal plasma. Regression lines of Cl-
`lNH functions and concentrations in the ranges 0.02—
`0.06 and 006-0. 18 g/l. respectively. were calculated.
`Vertical and horizontal lines indicate normal ranges of
`(‘l-INH concentration and apparent function.
`
`Discussion
`
`The results of this study suggest that there
`is a functionally critical level of Cl-lNH in
`recalcifted plasma. This evidence was ob-
`tained by analysis of l
`l
`l recalcified plasma
`samples from 2| patients with the common
`form of HAE under various types of therapy,
`and also from recalcified HAE plasma sup-
`plemented by recalcified normal plasma or
`replaced by purified Cl-lNH. The existence
`
`ofa functionally critical level ofCl-INH was
`
`found to be rooted in a nonlinear relationship
`between Cl -1NH concentration and apparent
`function. The value of the functionally criti-
`cal
`level was found to be approximately
`0.075 g/l (38% of normal); indeed. the func-
`tional adequacy of (Tl-INH, the concentra-
`tions of C4 within the normal range and the
`absence of attacks of edema were guaranteed
`
`as long as the antigen concentration did
`not
`fall below this threshold level. Thus.
`
`this is the first study to explain the obser-
`vation of this and other reports [18—23] of
`normal
`(‘4 concentrations
`in association
`with subnormal levels of (‘l-lNH in HAE
`
`(fig. 3).
`At the time when the preliminary results
`of this 4-year study were presented [24]. no
`other reports existed which could support the
`idea ofa nonlinear relationship between (‘1 -
`INH concentration and function; indeed all
`
`reports analyzing concentrations and func-
`tions of Cl-lNH by various methods fa-
`voured a linear relationship [25—31]. How-
`ever, in the meantime four publications pre-
`sented data which are compatible with a
`functionally critical level ofCl-INH concen-
`tration. Very recently, Ghebrahiwc! et a1. [32]
`studied the spontaneous breakdown of he-
`
`l'his material was copied
`it the NLM and may be
`Subject US Copyright Law:
`
`Page 8 of 13
`
`

`

`155
`Functionally (‘ritical Level of (‘l-lNH (‘oncentration
`
`Fig. 5. Concentrations and func-
`tions of (.‘l-lNH in a recalcilied
`mixture of HAE plasma with ele-
`vated factor B level and normal
`plasma (0) or purified ('i-INH (A).
`The indicated relationships of Cl-
`lNH concentrations and functions
`as they are given by the drawn
`curves are approximations and were
`not calculated. The normal
`range
`(RlD) is indicated by vertical lines,
`the apparent normal range of func-
`tional (II—[NH by horizontal lines.
`
`L l—INH antigen, git
`
`OO‘j
`
`01
`
`molytic complement in diluted sera obtained
`
`ccntration and function was reported by
`
`from patients with HAE. They found that the
`concentration ofCl -INH in NHS is in excess
`
`ofwhat is required to prevent the breakdown
`ofhemolytic complement in the diluted sam—
`
`ples. ln 1 HAE serum sample with no detect-
`able functional (‘l-lNH but substantial he-
`
`the
`molytic complement prior to dilution.
`replacement of highly purified and function-
`ally active C‘l—lNH resulted in a dose-depen-
`dent prevention of spontaneous complement
`reduction which reached its maximum effect
`at concentrations around 50% of normal. In
`
`[33]
`another publication. Yolvingmn et al.
`showed Cl-lNH concentrations of approxi-
`mately 0.08 g/l in sera of patients with HAE
`in association with normal and abnormal
`
`results of the immunodiffusion assay. Below
`Cl-INH concentrations of approximately
`0.075 g/l
`the immunodilTusion assay indi-
`cated a functionally diminished (Tl-[NH in
`all samples, whilst above a concentration of
`
`Doe/«'3 ct al. [34]. They analyzed in vitro the
`inhibition of the C4-converting activity after
`activation of C1 by aIgG of definite size in
`the presence of various amounts ofCl-INH.
`The maximum C4 consumption that could
`be reached at high concentrations of algG
`could be significantly reduced at a Cl-lNI-l:
`C4 ratio of only 0.6 although in vivo the
`value of normal Cl-INH:C4 ratio is 5-10.
`
`The fourth publication which supports the
`findings of this study is by Ziccardi [9]. He
`analyzed the concentration dependence of in-
`hibition by Cl-lNH of spontaneous Cl acti-
`vation. Although a different method was
`used to quantify functional Cl-INH, the re-
`sults obtained were similar to those of this
`
`study. A rise in Cl-lNH concentration from
`25 to 35% of normal was associated with a
`
`rise in apparent inactivating capacity of C [-
`lNH from 20 to 70% of normal. Variations
`in Cl-INH concentration above 35% of nor-
`
`approximately 0.095 g/l functional (‘l-INH
`was apparently normal. Further evidence oi'a
`
`nonlinear relationship between (7l-INH con-
`
`mal resulted only in minor changes of appar-
`ent functional activity of Cl-INH. Although
`Ziccara'i'r [9] results and those of this study
`
`This material wsseopied
`It the NLM and "my be
`Sobjcct USCopyright Law:
`
`Page 9 of 13
`
`

`

`156
`Spéith/Wiithrich/Butler
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`accord, it must be borne in mind that two
`different functions of Cl-INH were ana-
`
`
`
`
`
`
`lyzed.
`The existence of a threshold level of anti—
`
`
`
`
`
`
`
`
`
`
`
`
`
`gen for adequacy of functional Cl-INH is
`
`
`
`
`
`
`
`also plausible if the disappearance of Cl-
`
`
`
`
`
`
`
`INH and the decrease in C4 hemolytic titers
`
`
`
`
`
`is studied following the intravenous adminis-
`
`
`
`
`
`tration of partially puri

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket